PR97646

FRANKFURT, Sept. 2, 2022/Medianet International=KYODO JBN/--

PharmaLex Group, a leading provider of specialized services for the pharma,

biotech and medtech industries worldwide, has announced the opening of a new

branch in Beijing, China, giving global clients access to a team of regulatory

experts in the region.

As of September 2022, the newly established PharmaLex Beijing team, which

includes personnel joining from Bayer China, will be offering the full

PharmaLex value proposition for pharmacovigilance, regulatory affairs,

development consulting and quality management to global clients bringing

products to the China market. These offerings will make the office a center of

expertise in this growing marketplace. PharmaLex China will also be the local

contact point for Chinese-based biopharmaceutical companies that are developing

pharmaceuticals or medical devices with a goal of entering the European or US

markets.  

In addition, Pharmalex is preparing to open a second China office in Jinan,

which will extend the local footprint and provide clients with further access

to a regulatory talent pool in the country.

The China office will be led by Sophia Huang, Executive Director and Department

Head, who leads operations and business development and is supported by a

growing team, currently comprising 16 highly skilled regulatory submission and

publishing experts.  

"We welcome the opportunity to become part of the PharmaLex family, where we

can grow our services and reach with a company that has a strong focus on its

people and that has a reputation for transparency and reliability," Ms. Huang

said. "This is an exciting opportunity to continue to expand our skill set and

reach."

"APAC, and China in particular, is a strategic focus region for the

pharmaceutical industry, both from a global perspective and in terms of the

development of China-based companies," said PharmaLex CEO DR.Thomas Dobmeyer.  

"Onboarding the China team to the PharmaLex Organization underscores our

commitment to employing the right expertise in all our global offices.  We are

honored to welcome the team of highly experienced China personnel and together

develop our skills and capabilities with these valued colleagues while offering

them career and expertise development."

About us:

About PharmaLex <Confidence beyond compliance>:

PharmaLex is a leading provider of specialized services for the pharma, biotech

and medtech industries. We guide you from early strategic planning activities

and non-clinical requirements through clinical development, regulatory

submission processes and post-approval / maintenance post-launch activities.

Our experts use technology-enabled solutions to support you through the entire

product lifecycle. We deliver exceptional results — going above and beyond the

standard to deliver tailor-made solutions worldwide.

The PharmaLex Group now has over 3,000 employees, with 67 offices in 32

countries and more than 1,000 satisfied clients worldwide.

Contact details:

Ms. Elizabeth Hunt; PharmaLex GmbH; Manager External Communications

elizabeth.hunt@pharmalex.com

+00 353 86 811 2319

SOURCE: PharmaLex